drugset / Trial / NCT01609218
A Study of LY2140023 in Healthy Participants
RandomizedCrossoverOpen-labelOther
Summary
The study will evaluate the effect of activated charcoal on absorption of LY2140023. The study involves a single dose of 80 milligrams (mg) LY2140023 taken as 1 tablet by mouth 2 times during study (once with activated charcoal, once without activated charcoal). This study will last approximately 16 days, not including screening. Screening is required within 28 days prior to study entry.
Timeline
- Start
- 2012-06
- Primary completion
- 2012-09
- Completion
- 2012-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Activated Charcoal | Other / unclassified | 75 g | Oral |
| Subject | LY2140023 | Unknown | 80 mg | Oral |
Indications
No indication recorded.